International Journal of Contemporary Pediatrics

Chapala P et al. Int J Contemp Pediatr. 2026 Mar;13(3):480-485

http://www.ijpediatrics.com

pISSN 2349-3283 | eISSN 2349-3291

Clinical, laboratory and ultrasonographic correlation in assessing severity and outcome in dengue infection

Pallavi Chapala*, Kiranmayee Penubolu, Rajamanuri Venkata Soujanya, S. Narasimha Rao


Department of Pediatrics, Kamineni Academy of Medical Sciences and Research Centre, Hyderabad, India

Received: 07 February 2026

Revised: 15 February 2026

Accepted: 16 February 2026

*Correspondence:

Dr. Pallavi Chapala,

E-mail: chapalapallavi@gmail.com

Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

ABSTRACT

Background: Dengue infection is a major public health concern with clinical manifestations ranging from mild febrile illness to life-threatening shock syndrome. Early prediction of disease progression is vital for reducing morbidity and mortality. This study aimed to document the clinical profile of pediatric patients and evaluate the correlation of liver enzymes, viral serotypes, and abdominal ultrasonographic findings with the severity and outcome of dengue infection.

Methods: A prospective observational study was conducted over a period of 20 months involving 65 children (n=65) aged 1 month to 18 years admitted with confirmed dengue infection. Clinical features, liver function tests (AST, ALT, ALP), serotypes and abdominal ultrasound findings were analyzed. Statistical analysis was used to correlate these findings with disease severity.

Results: The majority of the study population were males (58.46%) with the highest incidence in the 1–5 year age group (35.38%). Fever was universally present, while hepatomegaly was observed in 20% of cases. DENV-2 was the predominant serotype (49.23%). Significant statistical differences were noted in Alkaline Phosphatase (ALP) and alanine transaminase (ALT) levels among different serotypes (p<0.05). Ultrasonography revealed warning signs such as ascites (36.9%) and gall bladder edema (30.7%). A statistically significant association was found between dengue severity and ultrasound warning signs (p<0.0000001), with an area under the ROC curve of 0.96.

Conclusions: Ultrasound warning signs are strong predictors of dengue severity in children. While liver enzyme levels vary significantly by serotype, abdominal ultrasonography serves as a highly sensitive and reliable non-invasive tool for the early prediction of severe dengue infection and timely management of pediatric dengue patients.

Keywords: Dengue infection, Liver enzymes, Viral Serotypes, Ultrasonography, Severity and outcome

INTRODUCTION

Dengue infection is the most prevalent arthropod-borne viral illness in humans, caused by the dengue virus of the Flaviviridae family. It remains one of the most important tropical infectious diseases globally. In the past 50 years, the prevalence of dengue fever has increased 30-fold, with geographic expansion to new countries and a shift from urban to rural setting. An estimated 50-100 million dengue infections occur annually, with approximately 2.5 billion people living in endemic regions. While case fatality rates range from 1% to 5%, appropriate treatment can reduce this to less than 1%.1 The 2009 World Health Organization criteria classify dengue into three levels of severity: dengue without warning signs, dengue with warning signs (abdominal pain, persistent vomiting, fluid accumulation, mucosal bleeding, lethargy, liver enlargement, increasing hematocrit with decreasing platelets), and severe dengue (severe plasma leakage, severe bleeding, or organ failure).2 According to recent national guidelines for clinical management of Dengue fever in 2015, dengue cases are classified as mild, moderate and severe dengue based on symptoms as described in figure-1 and ultrasound findings considered as warning signs are pleural effusion, ascites, gall bladder edema, hepatomegaly and splenomegaly.3 Although the liver is not a major target organ, hepatic dysfunction is a well-recognized feature of dengue, which shows a spectrum of liver function tests ranging from mild transaminase elevation to severe injury with liver cell failure.4-8 This dysfunction is more common in children with severe dengue and may result from direct viral effects on liver cells or dysregulated host immune responses.9,10 Additionally, abdominal ultrasound (USG) can detect polyserositis features such as gallbladder thickening, ascites, and pleural effusion, which are often associated with severe disease.11

Despite the burden of disease, few studies have focused on predicting severity and outcome in children using a combination of clinical, biochemical, and radiological parameters.12-14 This study was intended to predict the severity and outcome of dengue infection based on clinical parameters, liver enzymes (AST, ALT), viral serotypes, and abdominal ultrasound findings.

METHODS

This study was conducted in the Department of Pediatrics at Kamineni Academy of Medical Sciences and Research Centre, a tertiary care hospital in Hyderabad, Telangana. A prospective observational study was conducted over a period of 20 months during July 2023 to December 2024 consisting of 65 children (n=65) aged 1 month to 18 years diagnosed with dengue infection (dengue NS1 or IgM positive). Informed consent was obtained from parents/guardians of all study subjects.

Figure 1: Classification of dengue cases.
Figure 1: Classification of dengue cases.

Exclusion criteria

Children with known case of liver disease, heart disease, on antitubercular drugs, anticonvulsants, long-term steroid therapy and on regular blood transfusions for Thalassemia are excluded from the study.

The study involved the assessment of clinical profiles, including presenting symptoms (fever, vomiting, pain abdomen, bleeding manifestations) and signs (rash, hepatomegaly, splenomegaly). Laboratory investigations included complete blood counts, dengue serology (NS1, IgM, IgG), and liver function tests (AST, ALT, ALP). Viral serotyping was performed to identify the circulating strains (DENV-1, DENV-2, DENV-3). Abdominal ultrasonography was performed to identify findings such as hepatomegaly, splenomegaly, ascites, pleural effusion, and gallbladder (GB) edema. These findings were correlated with the severity of the disease based on WHO classification.

Statistical analysis

The data was entered in Microsoft Excel spreadsheet. Data was analyzed using Microsoft Excel 2010 and Epi Info 7.2.0.

RESULTS

Demographic profile

The study included 65 children. The age distribution (Figure 2) showed a peak in the 1–5-year age group (35.38%), followed by 11–15 years (32.30%) and 6–10 years (29.23%). Infants (age <1 year) constituted 3% of the population. Males comprised 58.46% of the study group, while females accounted for 41.54%.

Figure 2: Frequency of age wise distribution among dengue cases.
Figure 2: Frequency of age wise distribution among dengue cases.
Figure 3: Distribution of cases according to dengue classification.
Figure 3: Distribution of cases according to dengue classification.

Clinical presentation

Fever was the universal symptom, present in 100% of cases. Vomiting was the second most common symptom (30.77%), followed by cold (29.33%), abdominal pain (21.54%), melena (10.77%), and loose stools (9.23%). Less common symptoms included dark-colored urine, shortness of breath, headache, epistaxis, and seizures, each contributing less than 5%. On examination, rash was observed in 73.85% of patients. Hepatomegaly was detected clinically in 20% of cases, and splenomegaly in 7.69%.

Figure 4: ROC Curve showing the association between dengue severity and presence of warning signs.
Figure 4: ROC Curve showing the association between dengue severity and presence of warning signs.

Dengue serology and serotyping

NS1 antigen was positive in 69.23% of cases, IgM in 55.38%, and IgG in 41.54%. Serotyping data revealed that dengue serotype 2 was the predominant strain (49.23%), followed by serotype 3 (29.23%) and serotype 1 (21.54%).

Radiological findings

USG revealed abnormalities in 60% of cases. The most common findings were ascites (36.9%) and gallbladder edema (30.76%). Hepatomegaly was noted in 20% and splenomegaly in 7.69% of cases on USG. Chest X-rays were normal in 89.23% of cases, while 9.23% showed bilateral pleural effusion.

Disease severity

Based on WHO classification, figure 3 showing 55.38% of patients had moderate dengue, 36.92% had mild dengue, and 7.69% had severe dengue.

Correlations and associations

Liver enzymes vs serotypes

There was a statistically significant difference in alkaline phosphatase (ALP) and alanine transaminase (ALT) values across different serotypes (p=0.005 for ALP and p=0.00001 for ALT). The association between AST values and serotypes was not statistically significant (p=0.2).

USG findings vs severity

A strong correlation was observed between the severity of dengue and the presence of warning signs on ultrasound. Among patients with mild dengue, 100% had normal USG findings. In contrast, among those with moderate dengue, 34 out of 36 had abnormal USG findings. All 5 patients with severe dengue had abnormal USG findings. This association was statistically significant with a p value of <0.0000001.

Treatment and outcome

Platelet transfusion was required in 10.77% of cases. There was zero mortality in the study population; all 65 patients improved and were discharged.

Table 1: Distribution of cases according to symptoms.
Table reproduced from source PDF page 4
Table 2: Distribution of cases according to dengue serotypes.
Table reproduced from source PDF page 4
Table 3: Distribution of cases according to ultrasonography findings.
Table reproduced from source PDF page 4
Table 4: Association between AST, ALT and ALP with serotypes.
Table reproduced from source PDF page 4

**Statistically significant p value.

Table 5: Association of USG findings with severity.
Table reproduced from source PDF page 4

DISCUSSION

The present study provides a comprehensive clinical and laboratory profile of pediatric dengue patients. The mechanisms and pathogenesis of dengue hemorrhagic fever (DHF) are complex.15,16 Proposed risk factors include virus virulence, immune enhancement, cytokine storm and host genetic factors.17-22 The fluid loss due to increased capillary permeability leads to hypovolemic shock and multi-organ failure.23

Demographics and clinical profile

The finding that the 1–5-year age group was most affected (35.38%) contrasts with Chacko and Subramanyan, who reported a mean age of 7.87 years.12 However, the male predominance (58.46%) is consistent with findings by Subbalaxmi et al (57.4%) and Sigera et al (66.3%).13,24 Fever was the constant symptom (100%) across all studies compared. The study reported a significantly higher incidence of rash (73.85%) compared to Chacko et al and Subramanyan et al (5.48%) and Pooja et al (7%).12,14

Ultrasound findings and severity

USG abnormalities were prevalent, with ascites (36.9%) and GB edema (30.76%) being common. This is comparable to Subbalaxmi et al who reported ascites in 30.5%.13 The rate of pleural effusion (15.38%) was slightly lower than the 21% reported by Subbalaxmi et al.13 Previous studies by Santhosh et al have noted that sonographic features like thickened GB wall and polyserositis strongly favor a diagnosis of severe dengue.25 The ROC analysis (AUC 0.96) reinforces that USG warning signs are robust indicators for stratifying patients at risk.

Outcome

The zero-mortality rate in the study reflects the efficacy of timely management protocols, which compares favorably to the 2.74% mortality reported by Chacko and Subramanyan et al.12 This success is notable given the serious global impact of dengue, which is responsible for an estimated 20,000 deaths annually, predominantly in secondary dengue cases.

Limitations

This was a single-centre study conducted at a tertiary care hospital, which may limit the generalizability of findings to the broader community or different geographic regions. The sample size was relatively small (n=65), and the exclusion of children with pre-existing comorbidities (e.g., liver or heart disease) means results cannot be extrapolated to these high-risk groups. Additionally, as there was no mortality in this cohort, the study could not identify predictors specifically associated with fatal outcomes. Future multicentric studies with larger sample sizes are recommended to validate these findings.

CONCLUSION

This study comprehensively delineates the clinical profile and virological characteristics of pediatric dengue, identifying fever as a universal clinical feature and DENV-2 as the predominant serotype associated with significant hepatic dysfunction. This study validates abdominal ultrasonography not merely as a diagnostic tool, but as a definitive prognostic standard; the presence of warning signs-specifically gallbladder wall edema, ascites, and pleural effusion demonstrated a profound statistical correlation (p<0.0000001) with disease severity. These findings establish a crucial evidence base for prioritizing sonographic screening in pediatric protocols, demonstrating that using USG markers to guide early intervention is a viable strategy for reducing mortality, as evidenced by the 100% survival rate achieved in this cohort.

Funding: No funding sources

Conflict of interest: None declared

Ethical approval: The study was approved by the Institutional Ethics Committee

REFERENCES

  1. 1. WHO. Dengue and Dengue Hemorrhagic fever. Factsheet N 117. Geneva, World Health Organization. 2008.
  2. 2. Hadinegoro SRS. The revised WHO dengue case classification: does the system need to be modified. Paediat Int Child Health. 2012;32(1):33-8.
  3. 3. Kalayanarooj S. Clinical manifestations and management of dengue/DHF/DSS. Trop Med Health. 2011;39(4):83-7.
  4. 4. Itha S, Kashyap R, Krishnani N, Sararswat VA, Choudhari G, Agarwal R. Profile of liver involvement in dengue virus infection. Natl Med J India. 2005;18(3):127-30.
  5. 5. Prakash O, Almas A, Jafri SMW, Hamid S, Akthar J, Alishah H. Severity of acute hepatitis and its outcome in patients with dengue fever in a tertiary care hospital Karachi, Pakistan (South Asia). BMC Gastroenterol. 2010;10(43):1-8.
  6. 6. Chongsrisawat V, Hutagalung Y, Poovorawan Y. Liver function test results and outcome in children with acute liver failure due to dengue infection. Southeast Asian J Trop Med Public Health. 2009;40(1):47-53.
  7. 7. Souzza LJ, Nogueira RMR, Soares LC, Soares CEC, Ribas BF, Alves FP, Vieira FR, Pessanha FEB. The impact of dengue on liver function as evaluated by aminotransferase levels. Braz J Infect Dis. 2007;11(4):407-10.
  8. 8. Wong M, Shen E. The Utility of Liver Function Tests in Dengue. Ann Academy of Med. 2008;37(1):82-83.
  9. 9. Seneviratne SL, Malavige GN, de Silva HJ. Pathogenesis of liver involvement in dengue viral infections. Trans R Soc Trop Med Hyg. 2006;100(7):608.
  10. 10. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol. 2000;28(3):183-8.
  11. 11. Sharma G.K, Ajmera M, Gurjar R.S, Bairwa A.L. Role of ultrasonography (chest and abdomen) in diagnosis and early prediction of severity of dengue fever. Int J Pediatr Res. 2019;6(05):201-6.
  12. 12. Chacko B, Subramanian G. Clinical, laboratory and radiological parameters in children with dengue fever and predictive factors for dengue shock syndrome. J Trop Pediatr. 2017;63(4):278-85.
  13. 13. Subbalaxmi MVS, Kumar V,Ramanjaneyulu KH,Kapoor A Teja VD, Vemu Lakshmi Clinical, laboratory profile and outcome of dengue fever at a south Indian tertiary care hospital. J Clin Sci Res. 2017;6:160-70.
  14. 14. Rao P, Basavaprabhu A, Shenoy S, Dsouza N, Sridevi Hanaganahalli B. Correlation of Clinical Severity and Laboratory Parameters with Various Serotypes in Dengue Virus: A Hospital-Based Study. Int J Microbiol. 2020;2:1-6.
  15. 15. Green S, Rothman A (2006) Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis. 19(5):429–36.
  16. 16. Martina BEE, Koraka P, Osterhaus ADME (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev. 22(4):564–81.
  17. 17. Rico-Hesse R. Microevolution and virulence of dengue viruses. Adv Virus Res. 2003;59:315-41.
  18. 18. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol Baltim Md. 1950;61(11):6338–46.
  19. 19. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis. 1999;179(4):755–62.
  20. 20. Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol. 2011;11(8):532-43.
  21. 21. Stephens HA. HLA and other gene associations with dengue disease severity. Curr Top Microbiol Immunol. 2010;338:99-114.
  22. 22. Lan NTP, Hirayama K. Host genetic susceptibility to severe dengue infection. Trop Med Health. 2011;39(4):73–81
  23. 23. Malavige GN, Ogg GS. Pathogenesis of vascular leak in dengue virus infection. Immunology. 2017;151(3):261–9.
  24. 24. Sigera PC, Amarasekara R, Rodrigo C, Rajapakse S, Weeratunga P, De Silva NL, Huang CH, Sahoo MK, Pinsky BA, Pillai DR, Tissera HA, Jayasinghe S, Handunnetti S, Fernando SD. Risk prediction for severe disease and better diagnostic accuracy in early dengue infection; the Colombo dengue study. BMC Infect Dis. 2019;19(1):680.
  25. 25. Santhosh VR, Patil PG, Srinath MG, Kumar A, Jain A, Archana M. Sonography in the diagnosis and assessment of dengue Fever. J Clin Imaging Sci. 2014;4:14.